Related references
Note: Only part of the references are listed.High-Dose Therapy and Autologous Stem Cell Transplantation in First Relapse for Diffuse Large B Cell Lymphoma in the Rituximab Era: An Analysis Based on Data from the European Blood and Marrow Transplantation Registry
Nicolas Mounier et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy
Vincent Koppelmans et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation
Heather S. L. Jim et al.
CANCER (2012)
Alterations in Brain Activation During Working Memory Processing Associated With Breast Cancer and Treatment: A Prospective Functional Magnetic Resonance Imaging Study
Brenna C. McDonald et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Cancer- and Cancer Treatment-Associated Cognitive Change: An Update on the State of the Science
Tim A. Ahles et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Longitudinal Assessment of Chemotherapy-Induced Structural Changes in Cerebral White Matter and Its Correlation With Impaired Cognitive Functioning
Sabine Deprez et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Cognitive functions in primary CNS lymphoma after single or combined modality regimens
Denise D. Correa et al.
NEURO-ONCOLOGY (2012)
Association of anemia and cognitive dysfunction in patients with acute myelogenous leukemia and myelodysplastic syndrome
Susan M. Wood et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Low Risk of Chronic Graft-versus-Host Disease and Relapse Associated with T Cell-Depleted Peripheral Blood Stem Cell Transplantation for Acute Myelogenous Leukemia in First Remission: Results of the Blood and Marrow Transplant Clinical Trials Network Protocol 0303
Steven M. Devine et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Catechol-O-Methyltransferase Genotype Modulates Cancer Treatment-Related Cognitive Deficits in Breast Cancer Survivors
Brent J. Small et al.
CANCER (2011)
Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioning
Mehdi Hamadani et al.
HEMATOLOGICAL ONCOLOGY (2011)
Chemotherapy-Induced Structural Changes in Cerebral White Matter and its Correlation With Impaired Cognitive Functioning in Breast Cancer Patients
Sabine Deprez et al.
HUMAN BRAIN MAPPING (2011)
Prospective Neurocognitive Function Over 5 Years After Allogeneic Hematopoietic Cell Transplantation for Cancer Survivors Compared With Matched Controls at 5 Years
Karen L. Syrjala et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Neurobiological basis of chemotherapy-induced cognitive impairment: A review of rodent research
Riejanne Seigers et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2011)
Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study
Brenna C. McDonald et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Longitudinal Assessment of Cognitive Changes Associated With Adjuvant Treatment for Breast Cancer: Impact of Age and Cognitive Reserve
Tim A. Ahles et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Course of Cognitive Decline in Hematopoietic Stem Cell Transplantation: A Within-subjects Design
Melissa A. Friedman et al.
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY (2009)
Mental Status Changes After Hematopoietic Stem Cell Transplantation
Grace Chang et al.
CANCER (2009)
Ventricular enlargement as a possible measure of Alzheimers disease progression validated using the Alzheimers disease neuroimaging initiative database
Sean M. Nestor et al.
BRAIN (2008)
Clinical Patterns and Biological Correlates of Cognitive Dysfunction Associated with Cancer Therapy
Joerg Dietrich et al.
ONCOLOGIST (2008)
Cognitive function in breast cancer patients prior to adjuvant treatment
Tim A. Ahles et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Longitudinal cognitive follow-up in low grade gliomas
Denise D. Correa et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop
J. Vardy et al.
ANNALS OF ONCOLOGY (2008)
T cell-depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin
Ann A. Jakubowski et al.
BLOOD (2007)
Changes in cognitive functioning in the year after hematopoietic stem cell transplantation
Sheri R. Jacobs et al.
CANCER (2007)
Brain structure and function differences in monozygotic twins: Possible effects of breast cancer chemotherapy
Robert J. Ferguson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Case-referent comparison of cognitive functions in patients receiving haematopoietic stem-cell transplantation for haematological malignancies: Two-year follow-up results
Helena Harder et al.
EUROPEAN JOURNAL OF CANCER (2007)
Cognitive functions in primary central nervous system lymphoma: literature review and assessment guidelines
D. D. Correa et al.
ANNALS OF ONCOLOGY (2007)
Cognitive function in the acute course of allogeneic hematopoietic stem cell transplantation for hematological malignancies
F. Schulz-Kindermann et al.
BONE MARROW TRANSPLANTATION (2007)
Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy
Masatoshi Inagaki et al.
CANCER (2007)
Candidate mechanisms for chemotherapy-induced cognitive changes
Tim A. Ahles et al.
NATURE REVIEWS CANCER (2007)
Neurocognitive functions and quality of life in haematological patients receiving haematopoietic stem cell grafts: A one-year follow-up pilot study
H Harder et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2006)
Characteristics and correlates of cognitive functioning following bone marrow transplantation
M Booth-Jones et al.
BONE MARROW TRANSPLANTATION (2005)
Delayed neurotoxicity in primary central nervous system lymphoma
AMP Omuro et al.
ARCHIVES OF NEUROLOGY (2005)
Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome
CA Meyers et al.
CANCER (2005)
Assessment of pre-treatment cognitive performance in adult bone marrow or haematopoietic stem cell transplantation patients: A comparative study
H Harder et al.
EUROPEAN JOURNAL OF CANCER (2005)
Anticancer agents are potent neurotoxins in vitro and in vivo
W Rzeski et al.
ANNALS OF NEUROLOGY (2004)
Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy
PB Jacobsen et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2004)
Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplant
KL Syrjala et al.
BLOOD (2004)
The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma - Results of a prospective, randomized, longitudinal trial
JS Wefel et al.
CANCER (2004)
The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy
TA Ahles et al.
PSYCHO-ONCOLOGY (2003)
Prospective evaluation of neurological complications after allogeneic bone marrow transplantation
P Sostak et al.
NEUROLOGY (2003)
Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue
FB Hagemeister
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
Whole brain segmentation: Automated labeling of neuroanatomical structures in the human brain
B Fischl et al.
NEURON (2002)
Prospective evaluation of delayed central nervous system (CNS) toxicity of hyperfractionated total body irradiation (TBI)
F Wenz et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
Neurobehavioral toxicity of total body irradiation: A follow-up in long-term survivors
M Peper et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
Share Paper
